HYPERKALEMIA RISK COMPARISON IN PATIENTS ON VALSARTAN/SACUBITRIL: NORMAL RENAL PROFILE VERSUS ADVANCED CHRONIC KIDNEY DISEASE. RMSR [Internet]. 2025 May 27 [cited 2025 Aug. 7];3(5):1163-7. Available from: https://medscireview.net/index.php/Journal/article/view/1597